CLINICAL STUDY ON MT-141 IN THE FIELD OF SURGERY

MT-141, a novel antibiotic of the cephamycin group, was employed in the treatment of various infectious diseases encountered in the field of surgery, and the drug's clinical efficacy was investigated. MT-141 was administered to a total of 11 patients. In 3 cases, however, the drug was used conc...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 32; no. Supplement5; pp. 338 - 344
Main Authors ICHIKAWA, HIDEYUKI, KARIBE, NORIO, ASATO, SUSUMU, MIZUNO, TADASHI, KOIKE, HIDEO, HAYASH, SHIRO, KIYOSAWA, YUJI, MATSUSHITA, MASAMITSU, SHIOBARA, JUNSHIRO
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 1984
Online AccessGet full text

Cover

Loading…
More Information
Summary:MT-141, a novel antibiotic of the cephamycin group, was employed in the treatment of various infectious diseases encountered in the field of surgery, and the drug's clinical efficacy was investigated. MT-141 was administered to a total of 11 patients. In 3 cases, however, the drug was used concomitantly with other antibiotics, or it was administered with the purpose of preventing postoperative infections. Therefore, in these 3 cases, only the safety of the drug was evaluated and no efficacy evaluation was attempted. Administration of this agent was achieved by means of one-shot i. v. injection or i. v. drip infusion, in a dose of 1.0-2.0g, 1-2 times a day. The patients who were the subjects of evaluation of the efficacy of MT-141 consisted of 6 cases of cholangitis and 2 cases of peritonitis, or 8 cases in total. The results of the evaluation of the clinical efficacy of MT-141 were 4 cases of “excellent”, 3 cases of “good” and one case of “poor”. The efficacy rate was thus 88%. No subjective or objective symptoms of side effects were observed. Mild transient fluctuations in the serum GOT and GPT were observed in the laboratory tests in 4 of the cholangitis cases and the one case of peritonitis. These fluctuations were, however, considered not to be related to the effects of MT-141; they might be a pathological symptom of the bile duct infection, or might be due to the effects of a basal disease, surgical treatment, etc. In addition to the efficacy of MT-141 as mentioned above, the drug shows potent in vivo antibacterial effects against gram-negative bacteria. Therefore, MT-141 is thought to be a useful drug in the treatment of infections encountered in the field of surgery.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.32.Supplement5_338